|
|||||
|
|
A Case Report of Germline Compound Heterozygous Mutations in the BRCA1 Gene of an Ovarian and Breast Cancer Patient |
|
| Authors: | Ava Kwong Cecilia Y S Ho Vivian Y Shin Chun Hang Au Tsun Leung Chan Edmond S K Ma |
| Affiliation: | 1.Department of Surgery, The University of Hong Kong and University of Hong Kong-Shenzhen Hospital, Hong Kong, China;2.Department of Surgery, Hong Kong Sanatorium & Hospital, Hong Kong, China;3.Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong, China; (T.L.C.); (E.S.K.M.);4.Department of Molecular Pathology, Hong Kong Sanatorium & Hospital, Hong Kong, China; (C.Y.S.H.); (C.H.A.) |
| Abstract: | The germline carrier of the BRCA1 pathogenic mutation has been well proven to confer an increased risk of breast and ovarian cancer. Despite BRCA1 biallelic pathogenic mutations being extremely rare, they have been reported to be embryonically lethal or to cause Fanconi anemia (FA). Here we describe a patient who was a 48-year-old female identified with biallelic pathogenic mutations of the BRCA1 gene, with no or very subtle FA-features. She was diagnosed with ovarian cancer and breast cancer at the ages of 43 and 44 and had a strong family history of breast and gynecological cancers. |
| Keywords: | hereditary breast cancer compound heterozygous mutations Chinese Fanconi anemia |
